
    
      Treatment with only protease inhibitors might benefit HIV patients, who experience problems
      with the other antiretrovirals drugs classes. Another reason to only use protease inhibitors
      is that the remaining classes are spared. This leaves the option to use these classes in the
      future, for instance in cases of drug resistance. Laboratory data have shown that the
      combination of saquinavir with lopinavir and ritonavir may a good regimen. This study will
      explore this idea.
    
  